References
1. Anand IS, Carson P, Galle E, et al. Cardiac resynchronization therapy
reduces the risk of hospitalizations in patients with advanced heart
failure: results from the Comparison of Medical Therapy, Pacing and
Defibrillation in Heart Failure (COMPANION) trial. Circulation.2009;119(7):969-977.
2. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization
and death from progressive heart failure: a meta-analysis of randomized
controlled trials. JAMA. 2003;289(6):730-740.
3. Cleland JG, Freemantle N, Erdmann E, et al. Long-term mortality with
cardiac resynchronization therapy in the Cardiac Resynchronization-Heart
Failure (CARE-HF) trial. Eur J Heart Fail. 2012;14(6):628-634.
4. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC
Guidelines on cardiac pacing and cardiac resynchronization therapy: the
Task Force on cardiac pacing and resynchronization therapy of the
European Society of Cardiology (ESC). Developed in collaboration with
the European Heart Rhythm Association (EHRA). Eur Heart J.2013;34(29):2281-2329.
5. Bertoldi EG, Polanczyk CA, Cunha V, Ziegelmann PK, Beck-da-Silva L,
Rohde LE. Mortality reduction of cardiac resynchronization and
implantable cardioverter-defibrillator therapy in heart failure: an
updated meta-analysis. Does recent evidence change the standard of care?J Card Fail. 2011;17(10):860-866.
6. Kutyifa V, Stockburger M, Daubert JP, et al. PR interval identifies
clinical response in patients with non-left bundle branch block: a
Multicenter Automatic Defibrillator Implantation Trial-Cardiac
Resynchronization Therapy substudy. Circ Arrhythm Electrophysiol.2014;7(4):645-651.
7. Pastore G, Morani G, Maines M, et al. Patients with right bundle
branch block and concomitant delayed left ventricular activation respond
to cardiac resynchronization therapy. Europace.2018;20(11):e171-e178.
8. Goldenberg I, Kutyifa V, Klein HU, et al. Survival with
cardiac-resynchronization therapy in mild heart failure. N Engl J
Med. 2014;370(18):1694-1701.
9. Roque C, Trevisi N, Silberbauer J, et al. Electrical storm induced by
cardiac resynchronization therapy is determined by pacing on epicardial
scar and can be successfully managed by catheter ablation. Circ
Arrhythm Electrophysiol. 2014;7(6):1064-1069.
10. Fish JM, Brugada J, Antzelevitch C. Potential proarrhythmic effects
of biventricular pacing. J Am Coll Cardiol.2005;46(12):2340-2347.
11. Fish JM, Di Diego JM, Nesterenko V, Antzelevitch C. Epicardial
activation of left ventricular wall prolongs QT interval and transmural
dispersion of repolarization: implications for biventricular pacing.Circulation. 2004;109(17):2136-2142.
12. Medina-Ravell VA, Lankipalli RS, Yan GX, et al. Effect of epicardial
or biventricular pacing to prolong QT interval and increase transmural
dispersion of repolarization: does resynchronization therapy pose a risk
for patients predisposed to long QT or torsade de pointes?Circulation. 2003;107(5):740-746.
13. Deif B, Ballantyne B, Almehmadi F, et al. Cardiac resynchronization
is pro-arrhythmic in the absence of reverse ventricular remodelling: a
systematic review and meta-analysis. Cardiovascular research.2018;114(11):1435-1444.
14. Moss AJ, Brown MW, Cannom DS, et al. Multicenter automatic
defibrillator implantation trial-cardiac resynchronization therapy
(MADIT-CRT): design and clinical protocol. Ann Noninvasive
Electrocardiol. 2005;10(4 Suppl):34-43.
15. Cunnington C, Kwok CS, Satchithananda DK, et al. Cardiac
resynchronisation therapy is not associated with a reduction in
mortality or heart failure hospitalisation in patients with non-left
bundle branch block QRS morphology: meta-analysis of randomised
controlled trials. Heart. 2015;101(18):1456-1462.
16. Bilchick KC, Kamath S, DiMarco JP, Stukenborg GJ. Bundle-branch
block morphology and other predictors of outcome after cardiac
resynchronization therapy in Medicare patients. Circulation.2010;122(20):2022-2030.
17. Ouellet G, Huang DT, Moss AJ, et al. Effect of cardiac
resynchronization therapy on the risk of first and recurrent ventricular
tachyarrhythmic events in MADIT-CRT. J Am Coll Cardiol.2012;60(18):1809-1816.
18. Sandhu A, Bao H, Minges KE, et al. Use of Cardiac Resynchronization
Therapy Defibrillator in US Hospitals. JAMA Cardiology.2019;4(8):804-809.
19. Jimenez-Candil J, Hernandez J, Perdiguero P, et al. Prognostic
Significance of Nonsustained Ventricular Tachycardia Episodes Occurring
Early After Implantable Cardioverter-Defibrillator Implantation Among
Patients With Left Ventricular Dysfunction. Am J Cardiol.2016;118(10):1503-1510.
20. Singh JP, Hall WJ, McNitt S, et al. Factors influencing appropriate
firing of the implanted defibrillator for ventricular
tachycardia/fibrillation: findings from the Multicenter Automatic
Defibrillator Implantation Trial II (MADIT-II). J Am Coll
Cardiol. 2005;46(9):1712-1720.
21. Loring Z, Caños DA, Selzman K, et al. Left Bundle Branch Block
Predicts Better Survival in Women Than Men Receiving
Cardiac Resynchronization Therapy: Long-Term Follow-Up of ∼145,000
Patients. JACC: Heart Failure. 2013;1(3):237-244.
22. Cheng YJ, Zhang J, Li WJ, et al. More favorable response to cardiac
resynchronization therapy in women than in men. Circ Arrhythm
Electrophysiol. 2014;7(5):807-815.